Index
Recent articles
Spectrum Index: Self-harm hospitalizations, everolimus flops in phase 2 trial
This month’s newsletter also highlights deflated autism prevalence estimates from Shanghai, China.
Spectrum Index: Self-harm hospitalizations, everolimus flops in phase 2 trial
This month’s newsletter also highlights deflated autism prevalence estimates from Shanghai, China.
Spectrum Index: Dip in autism screening, null cancer risk, therapist surge
This month’s newsletter looks at a decline in well-child visits during the coronavirus pandemic, the autism-cancer connection and the sizeable fraction of autistic children who live in poverty.
Spectrum Index: Dip in autism screening, null cancer risk, therapist surge
This month’s newsletter looks at a decline in well-child visits during the coronavirus pandemic, the autism-cancer connection and the sizeable fraction of autistic children who live in poverty.
Spectrum Index: Rare genetic diagnoses, obesity odds, violence against children
This month’s newsletter looks at the minority of autistic people who have an identifiable genetic cause for their condition, and at the fraction of autistic children who are obese.
Spectrum Index: Rare genetic diagnoses, obesity odds, violence against children
This month’s newsletter looks at the minority of autistic people who have an identifiable genetic cause for their condition, and at the fraction of autistic children who are obese.
Spectrum Index: IQ deviations, rural disparities and underweight infants
This monthly newsletter offers quick statistics on the latest data-centric, autism research studies.
Spectrum Index: IQ deviations, rural disparities and underweight infants
This monthly newsletter offers quick statistics on the latest data-centric, autism research studies.
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”